Mark Berglund
Senior Principal Engineer in Synthetic Molecule Design and Development, Eli Lilly and Company
1st PD2M Workshop on Reaction Engineering in the Pharmaceutical Industry
May 10, 2023 to May 11, 2023
We are very excited to announce the 1st PD2M Workshop on Reaction Engineering in the Pharmaceutical Industry. This workshop brings together thought leaders from across multiple disciplines to discuss current and emerging strategies, and approaches to reaction engineering to facilitate biopharmaceutical development and increase process understanding. The theme of the PD2M Reaction Engineering workshop in 2023 is "Emerging trends in Pharmaceutical Reaction Engineering”.
Venue:
Hilton Philadelphia City Avenue,
4200 City Avenue,
Philadelphia, PA 19131 USA
Sponsors
Featured Speakers
-
-
Daniela Blanco
Co-founder and CEO, Sunthetics -
Jayachandran (Jay) Devaraj
Devaraj, Technical Program Leader for Continuous Processing Process Science & Technology, SMDD R&D, Corteva Agriscience, Indianapolis, USA -
Melda Sezen-Edmonds
Principal Scientist, Bristol Myers Squibb -
Ryan Hartman
Associate Professor in the Department of Chemical and Biomolecular Engineering, NYU Tandon School of Engineering -
Klavs Jensen
Warren K. Lewis Professor and Head of the Chemical Department, Massachusetts Institute of Technology -
Onkar Manjrekar
Principal Scientist, AbbVie -
Joseph Martinelli
Lilly Genetic Medicine -
Keith Mattern
Senior Scientist, Merck Research Labs -
Jonathan McMullen
-
Kevin Nagy
Senior Director of Engineering, Snapdragon Chemistry -
Neda Nazemifard
Associate Fellow and Process Modeling Lead, Takeda Pharmaceutical Co. -
Geoffrey Purdum
Principal Scientist, Bristol Myers Squibb -
Luke Rogers
V.P of Innovation, On Demand Pharmaceuticals -
Thomas Roper
Professor in the Chemical and Life Science Engineering Department, Virginia Commonwealth University -
Harrison Rose
Senior Scientist, Merck Research Laboratories -
Nathan Stover
-
David Thompson
-
Ryan Woods
Process Development Scientist, AMPAC Fine Chemicals